$686 Million is the total value of SMITH CHAS P & ASSOCIATES PA CPAS's 95 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INTC | Exit | Intel | $0 | – | -6,008 | -100.0% | -0.03% | – |
| APU | Exit | Amerigas Partners L P Unit L P | $0 | – | -4,892 | -100.0% | -0.03% | – |
| HEFA | Exit | iShares Trust iShares Currency | $0 | – | -54,942 | -100.0% | -0.22% | – |
| VXUS | Exit | Vanguard Star Fd Vanguard Tota | $0 | – | -51,242 | -100.0% | -0.38% | – |
| EEM | Exit | iShares Tr Msci Emerg Mkt | $0 | – | -98,974 | -100.0% | -0.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-04
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Apple Inc. | 42 | Q3 2023 | 7.8% |
| Berkshire Hathaway Inc Del Cl | 42 | Q3 2023 | 4.8% |
| J P Morgan Chase & Co | 42 | Q3 2023 | 4.5% |
| Ishares Tr S&P 500 Index | 42 | Q3 2023 | 3.9% |
| Cisco Sys Inc | 42 | Q3 2023 | 3.9% |
| Pfizer | 42 | Q3 2023 | 3.9% |
| Johnson & Johnson | 42 | Q3 2023 | 3.5% |
| Proctor & Gamble | 42 | Q3 2023 | 3.5% |
| Merck & Co. Inc. | 42 | Q3 2023 | 3.5% |
| Pepsico, Inc. | 42 | Q3 2023 | 3.1% |
View SMITH CHAS P & ASSOCIATES PA CPAS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-25 |
| 13F-HR | 2024-02-01 |
| 13F-HR | 2023-11-02 |
| 13F-HR | 2023-07-31 |
| 13F-HR | 2023-04-27 |
| 13F-HR | 2023-01-12 |
| 13F-HR | 2022-11-22 |
| 13F-HR | 2022-07-15 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-07 |
View SMITH CHAS P & ASSOCIATES PA CPAS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.